FURSOMIDE INJECTION IP 20 M

FURSOMIDE INJECTION IP 20 M Specification

Dosage Form
Liquid for injection

Indication
Edema, hypertension

Origin of Medicine
Allopathic

Salt Composition
Furosemide IP 20 mg

Pacakaging (Quantity Per Box)
10 ampoules per box

Drug Type
Prescription

Ingredients
Furosemide 20 mg

Physical Form
Injection

Function
Diuretic (promotes urine production)

Recommended For
Treatment of edema associated with congestive heart failure, liver cirrhosis, and renal disease including nephrotic syndrome

Dosage
As directed by the physician

Dosage Guidelines
Intravenous or intramuscular use only, not to be administered orally

Suitable For
For adults and children as prescribed

Quantity
Each vial contains 2 ml

Storage Instructions
Store below 30C, protect from light

FURSOMIDE INJECTION IP 20 M Trade Information

Minimum Order Quantity
500 Pieces

Payment Terms
Cash Advance (CA), Cash in Advance (CID), Cheque

Packaging Details
boxes

Main Export Market(s)
Middle East

About FURSOMIDE INJECTION IP 20 M

Experience wondrous relief and instant savings with FURSOMIDE INJECTION IP 20 M, an elite solution crafted for the treatment of edema due to congestive heart failure, liver cirrhosis, and renal disease. This clear, colorless liquid offers unprecedented efficacy as a diuretic, promoting urinary output where fluid retention is a concern. Conveniently packaged in glass ampoules (2 ml each), each box contains 10 ampoules. Reserve yours nowthis in-demand product is suitable for adults and children as prescribed. Complies fully with IP standards for your assurance. Administered intravenously or intramuscularly, always under medical supervision, for reliable and effective outcomes. Store below 30C and protect from light.

Elite Use & Special Features of FURSOMIDE INJECTION IP 20 M

FURSOMIDE INJECTION IP 20 M is designed for intravenous or intramuscular administration, making it ideal for both urgent hospital interventions and controlled clinical settings. This allopathic diuretic is suitable for adults and children under medical direction. Its elite features include a clear, colorless formulation in secure glass ampoules, a shelf life of 24 months, and compliance with stringent Indian Pharmacopoeia (IP) standards. Each dose delivers 20 mg of furosemide, ensuring consistent and effective therapy for fluid overload conditions.

Payment Terms, Domestic Market, & Packaging at a Glance

Stock ready for handover, FURSOMIDE INJECTION IP 20 M is available across the domestic mar, ensuring prompt supply to hospitals and clinics. Multiple secure payment terms are offered for buyer convenience. Each box contains 10 glass ampoules, carefully packaged to maintain product integrity during transit. Whether you are a supplier or trader based in India, reserve your supply to stay ahead in the in-demand market for diuretic medications.

FAQs of FURSOMIDE INJECTION IP 20 M:

Q: How is FURSOMIDE INJECTION IP 20 M administered?

A: FURSOMIDE INJECTION IP 20 M is administered either intravenously (IV) or intramuscularly (IM) under the direction of a medical professional. It should never be given orally.

Q: What conditions does FURSOMIDE INJECTION IP 20 M treat?

A: This injection is indicated for the management of edema associated with congestive heart failure, liver cirrhosis, and kidney disorders such as nephrotic syndrome. It may also be prescribed for certain cases of hypertension.

Q: When should FURSOMIDE INJECTION IP 20 M not be used?

A: FURSOMIDE INJECTION IP 20 M is contraindicated in individuals with known hypersensitivity to furosemide or in those experiencing anuria (failure of the kidneys to produce urine).

Q: Where should FURSOMIDE INJECTION IP 20 M be stored?

A: The ampoules should be stored below 30C and protected from light to ensure the product maintains its efficacy and stability throughout its shelf life.

Q: What are the packaging details for FURSOMIDE INJECTION IP 20 M?

A: Each box contains 10 glass ampoules, each ampoule holding 2 ml of the clear, colorless injection solution. The packaging is designed to comply with Indian Pharmacopoeia (IP) standards.